EUVIMEDEUVIMED entdecken
Multizentrische StudieValidierungsstudie

The Inaugural Pre‐Treatment Nomogram to Assess the Eight‐Week Efficacy of Dapoxetine: A Prospective Multi‐Center Study

Guangdong Hou iD, Geng Zhang iD, Ming Gao iD, Yu Zheng iD, Elena Colonnello, Andrea Sansone, Lei Zhang, Tommaso B Jannini, Ping Meng, Siyan Zhang iD, Emmanuele A Jannini iD, Jianlin Yuan iD

Andrology · 2026

DOI: 10.1111/andr.70128 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Andrology, 2026. Verfasst von Guangdong Hou und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Tangdu Hospital, Fourth Military Medical University, Xi'an, China. Hauptthemen laut MEDLINE: Naphthalenes, Benzylamines, Nomograms, Premature Ejaculation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Basic Research Program of Shaanxi Province, Rapid Response Program Project of the Fourth Military Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Although a nomogram for predicting the efficacy of dapoxetine (DapE‐Nomo) has already been developed, its reliability is limited due to only 4 weeks of follow‐up and a lack of external validation. Several patients with premature ejaculation (PE) achieve satisfactory therapeutic effects after longer periods of treatment clinically, we therefore aimed to develop and validate an 8‐week DapE‐Nomo.

Methods

The training cohort included 243 patients with lifelong PE from Xijing Hospital and Northwest Women's and Children's Hospital (Jan 2019–Jul 2020), while the validation cohort comprised 397 patients from Xijing Hospital and Xi'an Daxing Hospital (Aug 2020–Jan 2022). Efficacy was measured using the Clinical Global Impression of Change (CGIC) scale, with a CGIC score ≥ 1 indicating an improvement (iCGI). LASSO regression was utilized to identify the most valuable predictors (MVPs) of iCGI. The DapE‐Nomo was developed utilizing logistic regression coefficients of MVPs and validated across both cohorts.

Results

After 8 weeks of medication, 47.7% of patients in the training cohort and 47.6% in the validation cohort achieved iCGI. MVPs of iCGI included intravaginal ejaculation latency time, difficulty delaying ejaculation, and education level. The DapE‐Nomo showed discriminatory abilities of 0.722 and 0.709 in internal and external validations, respectively, with satisfactory calibration and clinical utility in both. The optimal cutoff value of the DapE‐Nomo was identified as 153.4 in both cohorts. Individuals with scores ≥153.4 exhibited a 3.833‐fold and 4.137‐fold chance of achieving iCGI, respectively, compared with those with scores < 153.4.

Conclusion

We constructed and validated the inaugural 8‐week DapE‐Nomo. In outpatient settings, it will enable andrologists to more accurately evaluate the efficacy and promptly adjust treatment plans for patients with scores below 153.4. Moreover, It will help patients who've taken dapoxetine for 4 weeks with poor results decide whether to stop.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NaphthalenesBenzylaminesNomogramsPremature EjaculationSelective Serotonin Reuptake InhibitorsHumansMaleProspective StudiesAdultTreatment OutcomeReproducibility of Results

Stichwörter der Autor:innen

LASSOdapoxetinenomogrampremature ejaculation

Substanzen

dapoxetineNaphthalenesBenzylaminesSelective Serotonin Reuptake Inhibitors

Autor:innen und Institutionen

  • Department of Urology, Tangdu Hospital, Fourth Military Medical University, Xi'an, China.
  • Xijing Hospital, Fourth Military Medical University, Xi'an, China.
  • Department of Urology, Xi'an Daxing Hospital, Xi'an, China.
  • Northwest Women's and Children's Hospital, Xi'an, China.
  • Medical Innovation Center, Fourth Military Medical University, Xi'an, China.
  • Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.

ORCID-Profile: Guangdong Hou, Geng Zhang, Ming Gao, Yu Zheng, Siyan Zhang, Emmanuele A Jannini, Jianlin Yuan

Förderung

  • National Natural Science Foundation of China
  • Natural Science Basic Research Program of Shaanxi Province
  • Rapid Response Program Project of the Fourth Military Medical University

Zitieren

APA

Hou, G., Zhang, G., Gao, M., Zheng, Y., Colonnello, E., Sansone, A., Zhang, L., Jannini, T. B., Meng, P., Zhang, S., Jannini, E. A., & Yuan, J. (2026). The Inaugural Pre‐Treatment Nomogram to Assess the Eight‐Week Efficacy of Dapoxetine: A Prospective Multi‐Center Study. Andrology. https://doi.org/10.1111/andr.70128

Vancouver

Hou G, Zhang G, Gao M, Zheng Y, Colonnello E, Sansone A, et al. The Inaugural Pre‐Treatment Nomogram to Assess the Eight‐Week Efficacy of Dapoxetine: A Prospective Multi‐Center Study. Andrology. 2026. doi:10.1111/andr.70128

BibTeX
@article{Hou2026,
  author = {Hou, Guangdong and Zhang, Geng and Gao, Ming and Zheng, Yu and Colonnello, Elena and Sansone, Andrea and Zhang, Lei and Jannini, Tommaso B and Meng, Ping and Zhang, Siyan and Jannini, Emmanuele A and Yuan, Jianlin},
  title = {The Inaugural Pre‐Treatment Nomogram to Assess the Eight‐Week Efficacy of Dapoxetine: A Prospective Multi‐Center Study},
  journal = {Andrology},
  year = {2026},
  doi = {10.1111/andr.70128}
}
Kostenlos starten →